Is BRKR or EYPT more undervalued in 2026?

CirclFi compares Bruker Corporation (BRKR) and EyePoint, Inc. (EYPT) using 13 institutional-grade valuation models. BRKR has a Quality of Company score of 8.1/10 while EYPT scores 5.6/10.

Which is a better buy — BRKR or EYPT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BRKR and EYPT valuations compare?

BRKR at $58.89 and EYPT at $13.58 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BRKR vs EYPT Valuation Comparison 2026 — Intrinsic Value Analysis

BRKR

Laboratory Analytical Instruments

Bruker Corporation

Quality

8.1

out of 10

Value Trap

LOW

Price

$58.89

Last close

Models

12/13

Active

EYPT

Laboratory Analytical Instruments

EyePoint, Inc.

Quality

5.6

out of 10

Value Trap

SAFE

Price

$13.58

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	BRKR Fair Value	BRKR Upside	EYPT Fair Value	EYPT Upside
Bayesian DCF	Intrinsic	$0.50	-98.9%	$3.76	-72.3%
Earnings Power Value	Intrinsic	$13.45	-77.2%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$4.13	-69.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BRKR vs EYPT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BRKR vs EYPT — Which Stock Is More Undervalued?

BRKR scores higher with a 8.1/10 quality rating vs EYPT's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bruker Corporation (BRKR) and EyePoint, Inc. (EYPT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BRKR currently trades at $58.89 with a QOC of 8.1/10, while EYPT trades at $13.58 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).